Skip to main content
. 2023 Apr 30;12(2):66–74. doi: 10.14740/jh1090

Figure 3.

Figure 3

The forest plot of the odds ratio of grade I-V hematological adverse events comparing the additional immune checkpoint inhibitor use with control therapy. (a) Anemia. (b) Neutropenia. (c) Thrombocytopenia. CI: confidence interval.